Prevention

Periodic health assessment

  • INESSS Institut national d'excellence en santé et services sociaux
  • HC Hypertension Canada
WhoMeasure at appropriate visits Not every visit if not indicated.
Diagnose≥130/80 Office = home = daytime ABPM.
TargetSystolic <130 if tolerated. No diastolic target once systolic at goal.
Start≥140/90 any risk: start drugs 130–139: drugs only if high cardiovascular risk.
  • CTFPHC Canadian Task Force on Preventive Health Care
DecisionMaleFemale
ScreenOne-time ultrasound, ages 65-80 (weak). Do not screen men >80 (weak).Do not screen women (strong).
  • Higher risk in smokers noted;
  • CTFPHC made no separate smoker recommendation.
  • INESSS Institut national d'excellence en santé et services sociaux
  • MSSS Ministère de la Santé et des Services sociaux
  • ObC Obesity Canada
  • Measure height, weight, and BMI in all adults.
  • Waist circumference if BMI 25-35.
  • Treat obesity as chronic disease (health goals, not weight alone).
  • PIQ Protocole d'immunisation du Québec (MSSS)
DecisionGuideline
CalendarUse PIQ, not NACI.
PregnancydcaT every pregnancy, prefer 26-32 w
Age 50dT (no booster if dose from age 40)
Age 65Pneu-C-21 + influenza annually
Age 71Zona-SU
  • CSEP Canadian Society for Exercise Physiology
DecisionGuideline
18-64 opens in a new tab≥150 min/wk MVPA; strength ≥2x/wk; sleep 7-9h; sedentary ≤8h (screens ≤3h recreational)
65+ opens in a new tabSame 150 + strength 2x + balance; sleep 7-8h

Tests when indicated — not an annual chem panel.

  • INESSS Institut national d'excellence en santé et services sociaux
  • PEER PEER (Patients, Experience, Evidence, Research), CFPC
  • CCS Canadian Cardiovascular Society
  • HC Hypertension Canada
  • DC Diabetes Canada
  • CTFPHC Canadian Task Force on Preventive Health Care
  • ObC Obesity Canada
  • CWC Choosing Wisely Canada
DecisionGuideline
CBC
Not annual in asymptomatic EMP When indicated. CANMAT depression: CBC + TSH only.

CWC family medicine opens in a new tabCANMAT

Cr / eGFR
Not annual alone With lipid screen (CCS). At hypertension diagnosis (INESSS).

INESSS 2026CCS 2021 lipids opens in a new tab

Na/K
Not annual At hypertension diagnosis.

INESSS 2026 opens in a new tabCMAJ opens in a new tab

ALT
Not every EMP Obesity Canada: NAFLD/MASH during obesity assessment.

Obesity Canada adult CPG opens in a new tab

Glycemia
≥40 every 3 years Fasting plasma glucose and/or HbA1c.

Diabetes Canada chapter 4 opens in a new tabDiabetes Canada chapter 3 opens in a new tab

Lipids
Differs
Men ≥40, women ≥50 Reassess CVD risk/lipids at most every 5 years; prefer 10 years if untreated.

PEER 2023 in CFP opens in a new tab

Men 40 and over; women 40 and over or postmenopausal

CCS 2021 lipids opens in a new tab

Lp(a)
Differs
Once at initial screening

CCS 2021 lipids opens in a new tab

Against Lp(a) or ApoB to determine cardiovascular risk

PEER 2023 in CFP opens in a new tab

Non-fasting
Non-fasting for most

CCS 2021 lipids opens in a new tabPEER 2023 in CFP opens in a new tab

eGFR
When screening lipids (CCS): include eGFR and FPG or A1C.

CCS 2021 lipids opens in a new tab

B12
Clinical indication only

Choosing Wisely Canada family medicine opens in a new tab

uACR
At hypertension diagnosis Dipstick or UA + uACR (INESSS). CCS: also with lipids if eGFR <60 or hypertension or diabetes.

INESSS 2026CCS 2021 lipids opens in a new tab

TSH
Do not screen asymptomatic non-pregnant adults for thyroid dysfunction.

Test if

  • Symptoms or risk factors
    • Prior thyroid disease/surgery;
    • thyroid meds, lithium, amiodarone;
    • radioiodine / head-neck RT;
    • pituitary/hypothalamic disease.

CMAJ 2019 opens in a new tabCTFPHC thyroid FAQ opens in a new tabCWC family medicine opens in a new tabCTFPHC thyroid opens in a new tab

  • CTFPHC Canadian Task Force on Preventive Health Care
  • OC Osteoporosis Canada
DecisionGuideline
When / how
Differs
Females ≥65: Canadian FRAX without BMD first, then shared decision-making. Against screening females 40-64 and males ≥40.

CTFPHC 2023 opens in a new tabFRAX aid opens in a new tab

BMD if ≥70 with no CRF / ≥65 with 1 CRF / 50-64 if prior OP fracture or ≥2 CRFs. Prefer FRAX with BMD.

Osteoporosis Canada 2023 opens in a new tab

  • MSSS Ministère de la Santé et des Services sociaux
  • CTFPHC Canadian Task Force on Preventive Health Care
DecisionGuideline
MSSS
Differs
≤25 sexually active: recommend chlamydia; gonorrhea for women; for men only Terres-Cries / Nunavik.

MSSS document-000098 opens in a new tab

Under 30: opportunistic annual CT+GC (CTFPHC).

CTFPHC CT/GC opens in a new tab

  • HCSC Health Canada
  • CTFPHC Canadian Task Force on Preventive Health Care
  • CCCDTD Canadian Consensus Conference on the Diagnosis and Treatment of Dementia
DecisionGuideline
Do not screenAsymptomatic adults ≥65 (no instrument).
Assess whenPatient, clinician, or caregiver concern, or signs/symptoms affecting daily life.
HowInformant + MMSE; MoCA if MCI or MMSE ≥24/30.
  • CTFPHC Canadian Task Force on Preventive Health Care
  • Do not use a depression questionnaire to screen adults ≥18 (strong).
  • MSSS Ministère de la Santé et des Services sociaux
  • CTFPHC Canadian Task Force on Preventive Health Care
  • Do not screen if risk is not elevated.
  • MSSS: transfusion before April 1992, among others.
  • CTFPHC Canadian Task Force on Preventive Health Care
  • Do not perform a screening pelvic examination.
  • CSBPR Canadian Stroke Best Practice Recommendations (Heart & Stroke)
  • Do not use ASA for routine primary prevention (CSBPR).
  • INESSS Institut national d'excellence en santé et services sociaux
  • MSSS Ministère de la Santé et des Services sociaux
SiteMaleFemale
Cervical-HPV 25–65 / every 5 y (immunocompetent). Stop 65 (INESSS default cease; MSSS max age 65).
Breast-50-74 / every 2 y (PQDCS)
Colorectal50-74 / every 2 y (FIT avg risk)50-74 / every 2 y (FIT avg risk)
Lung55-74; smoked ≥20 y; refer CCSR55-74; smoked ≥20 y; refer CCSR
ProstateDo not offer systematically. If requested: 55-69.
-

Reviewed 24 August 2026 against the official sources below.

Sources

Blue square: Québec · red round: Canada. The code names the body; each section's key gives its full name.

INESSS reminder, primary hypertension, August 2026 opens in a new tab
INESSS strategies de cessation tabagique opens in a new tab
INESSS cessation tool (English PDF) opens in a new tab
INESSS opens in a new tab
INESSS APS HTML opens in a new tab
PIQ regular immunization calendar, last update 30 Jun 2026 opens in a new tab
J'ARRETE cessation opens in a new tab
MSSS ITSS to seek by risk factor, document-000098 opens in a new tab
PQDCS Quebec.ca hub opens in a new tab
MSSS PQDCCR opens in a new tab
Quebec.ca lung professionals opens in a new tab
PEER 2023 CVD primary prevention in CFP opens in a new tab
CCS 2021 dyslipidemia guideline opens in a new tab
Hypertension Canada diagnosis, 2025 opens in a new tab
Hypertension Canada 2025 primary care guideline, CMAJ opens in a new tab
Diabetes Canada CPG chapter 4, screening opens in a new tab
Diabetes Canada CPG chapter 3, diagnosis opens in a new tab
CSEP 24-Hour Movement Guidelines adults 18-64 opens in a new tab
CSEP 24-Hour Movement Guidelines adults 65+ opens in a new tab
Health Canada food guide opens in a new tab
Health Canada eat well plate opens in a new tab
CTFPHC abdominal aortic aneurysm, 2017 opens in a new tab
CTFPHC tobacco smoking in adults, 2025 opens in a new tab
CTFPHC asymptomatic thyroid dysfunction, CMAJ 2019 opens in a new tab
CTFPHC thyroid dysfunction clinician FAQ, 2024 opens in a new tab
CTFPHC asymptomatic thyroid dysfunction opens in a new tab
CTFPHC fragility fractures, 2023 opens in a new tab
CTFPHC Canadian FRAX decision aid opens in a new tab
CTFPHC chlamydia and gonorrhea opens in a new tab
CTFPHC cognitive impairment opens in a new tab
CTFPHC depression in adults update, clinician summary opens in a new tab
CTFPHC hepatitis C opens in a new tab
CTFPHC screening pelvic examination opens in a new tab
Obesity Canada adult CPG, assessment opens in a new tab
Choosing Wisely Canada family medicine opens in a new tab
Osteoporosis Canada 2023 CPG executive summary opens in a new tab
Canadian Stroke Best Practices ASA for prevention opens in a new tab
CCCDTD5, Recommendations of the 5th Canadian Consensus Conference on the diagnosis and treatment of dementia (Alzheimers Dement 2020;16(8):1182-1195) opens in a new tab